Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

NCT: NCT03635424 · ACTIVE_NOT_RECRUITING

NCT IDNCT03635424
StatusACTIVE_NOT_RECRUITING
Start Date2018-10-30
Completion2030-12

Brief Summary

The objective of the trial is to evaluate the procedural safety and efficacy of the Medtronic TAVR system in patients with bicuspid aortic anatomy and severe aortic stenosis at low risk for SAVR

Frequently Asked Questions

What is Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study?

Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study is a clinical trial registered under NCT03635424. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03635424?

The current status of NCT03635424 (Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study) is: ACTIVE_NOT_RECRUITING.

When did Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study start?

Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study started on 2018-10-30.

Related Devices

PMA P100047 Ventricular (assist) bypass Medtronic

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑